Clofarabine structure
|
Common Name | Clofarabine | ||
---|---|---|---|---|
CAS Number | 123318-82-1 | Molecular Weight | 303.677 | |
Density | 2.1±0.1 g/cm3 | Boiling Point | 599.5±60.0 °C at 760 mmHg | |
Molecular Formula | C10H11ClFN5O3 | Melting Point | 228-2310C | |
MSDS | Chinese USA | Flash Point | 316.4±32.9 °C | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of ClofarabineClofarabine(Clolar; Clofarex) inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.IC50 Value: 65 nMTarget: in vitro: Clofarabine is a second generation purine nucleoside analog with antineoplastic activity. It is phosphorylated intracellularly, which inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase, resulting in inhibition of DNA repair and synthesis of DNA and RNA. This nucleoside analog also disrupts mitochondrial function and membrane integrity, resulting in the release of pre-apoptotic factors, including cytochrome C and apoptotic-inducing factor, which activate apoptosis.in vivo: Clofarabine is used for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children, after at least two other types of treatment have failed. |
Name | clofarabine |
---|---|
Synonym | More Synonyms |
Description | Clofarabine(Clolar; Clofarex) inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.IC50 Value: 65 nMTarget: in vitro: Clofarabine is a second generation purine nucleoside analog with antineoplastic activity. It is phosphorylated intracellularly, which inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase, resulting in inhibition of DNA repair and synthesis of DNA and RNA. This nucleoside analog also disrupts mitochondrial function and membrane integrity, resulting in the release of pre-apoptotic factors, including cytochrome C and apoptotic-inducing factor, which activate apoptosis.in vivo: Clofarabine is used for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children, after at least two other types of treatment have failed. |
---|---|
Related Catalog | |
References |
Density | 2.1±0.1 g/cm3 |
---|---|
Boiling Point | 599.5±60.0 °C at 760 mmHg |
Melting Point | 228-2310C |
Molecular Formula | C10H11ClFN5O3 |
Molecular Weight | 303.677 |
Flash Point | 316.4±32.9 °C |
Exact Mass | 303.053436 |
PSA | 119.31000 |
LogP | 0.24 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.844 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300 |
Precautionary Statements | P264-P301 + P310 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | Xi,C |
Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . |
Safety Phrases | S26-S36-S45-S36/37/39 |
RIDADR | UN 2735 8/PG 3 |
WGK Germany | 3 |
RTECS | DP5550000 |
Packaging Group | III |
Hazard Class | 8 |
Precursor 9 | |
---|---|
DownStream 2 | |
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
Eur. J. Cancer 51 , 2008-21, (2015) MLL-rearranged acute lymphoblastic leukaemia (ALL) in infants is the most difficult-to-treat type of childhood ALL, displaying a chemotherapy-resistant phenotype, and unique histone modifications, gen... |
|
Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.
Cancer Chemother. Pharmacol. 75 , 897-906, (2015) Clofarabine, a deoxyadenosine analog, was an active anticancer drug in our in vitro high-throughput screening against mouse ependymoma neurospheres. To characterize the clofarabine disposition in mice... |
|
Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
J. Korean Med. Sci. 29(11) , 1464-72, (2014) Mcl-1 and Bcl-xL, key anti-apoptotic proteins of the Bcl-2 family, have attracted attention as important molecules in the cell survival and drug resistance. In this study, we investigated whether inhi... |
Clofarex |
(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol |
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxyméthyl)tétrahydrofuran-3-ol |
9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)- |
2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine |
(2R,3R,4S,5R)-5-(6-Amino-2-chlor-9H-purin-9-yl)-4-fluor-2-(hydroxymethyl)tetrahydrofuran-3-ol |
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol |
2-chloro-2'-arabino-fluoro-2'-deoxyadenosine |
Cl-F-Ara-A |
Clofarabine |
Clofarabine [USAN] |
Clolar |
2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine |
MFCD00871077 |